Ceramide-induced autophagy

To junk or to protect cells?

Sophie Pattingre, Chantal Bauvy, Thierry Levade, Beth Levine, Patrice Codogno

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Ceramide is a sphingolipid bioactive molecule that induces apoptosis and other forms of cell death, and triggers macroautophagy (referred to below as autophagy). Like amino acid starvation, ceramide triggers autophagy by interfering with the mTOR-signaling pathway, and by dissociating the Beclin 1:Bcl-2 complex in a c-Jun N-terminal kinase 1 (JNK1)-mediated Bcl-2 phosphorylation-dependent manner. Dissociation of the Beclin 1:Bcl-2 complex, and the subsequent stimulation of autophagy have been observed in various contexts in which the cellular level of long-chain ceramides was increased. It is notable that the conversion of short-chain ceramides (C2-ceramide and C6-ceramide) into long-chain ceramide via the activity of ceramide synthase is required to trigger autophagy. The dissociation of the Beclin 1:Bcl-2 complex has also been observed in response to tamoxifen and PDMP (an inhibitor of the enzyme that converts ceramide to glucosylceramide), drugs that increase the intracellular level of long-chain ceramides. However, and in contrast to starvation, overexpression of Bcl-2 does not blunt ceramide-induced autophagy. Whether this autophagy that is unchecked by forced dissociation of the Beclin 1:Bcl-2 complex is related to the ability of ceramide to trigger cell death remains an open question. More generally, the question of whether ceramide-induced autophagy is a dedicated cell death mechanism deserves closer scrutiny.

Original languageEnglish (US)
Pages (from-to)558-560
Number of pages3
JournalAutophagy
Volume5
Issue number4
DOIs
StatePublished - May 16 2009

Fingerprint

Ceramides
Autophagy
Cell Death
Starvation
Mitogen-Activated Protein Kinase 8
Glucosylceramides
Sphingolipids
Enzyme Inhibitors
Tamoxifen
Phosphorylation
Apoptosis
Amino Acids
Beclin-1

Keywords

  • Bcl-2
  • Beclin 1
  • c-Jun N-terminal kinase
  • Cell death
  • Macroautophagy
  • Sphingolipids

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Pattingre, S., Bauvy, C., Levade, T., Levine, B., & Codogno, P. (2009). Ceramide-induced autophagy: To junk or to protect cells? Autophagy, 5(4), 558-560. https://doi.org/10.4161/auto.5.4.8390

Ceramide-induced autophagy : To junk or to protect cells? / Pattingre, Sophie; Bauvy, Chantal; Levade, Thierry; Levine, Beth; Codogno, Patrice.

In: Autophagy, Vol. 5, No. 4, 16.05.2009, p. 558-560.

Research output: Contribution to journalArticle

Pattingre, S, Bauvy, C, Levade, T, Levine, B & Codogno, P 2009, 'Ceramide-induced autophagy: To junk or to protect cells?', Autophagy, vol. 5, no. 4, pp. 558-560. https://doi.org/10.4161/auto.5.4.8390
Pattingre, Sophie ; Bauvy, Chantal ; Levade, Thierry ; Levine, Beth ; Codogno, Patrice. / Ceramide-induced autophagy : To junk or to protect cells?. In: Autophagy. 2009 ; Vol. 5, No. 4. pp. 558-560.
@article{29083ae173344c1dbf3d56c7de810d63,
title = "Ceramide-induced autophagy: To junk or to protect cells?",
abstract = "Ceramide is a sphingolipid bioactive molecule that induces apoptosis and other forms of cell death, and triggers macroautophagy (referred to below as autophagy). Like amino acid starvation, ceramide triggers autophagy by interfering with the mTOR-signaling pathway, and by dissociating the Beclin 1:Bcl-2 complex in a c-Jun N-terminal kinase 1 (JNK1)-mediated Bcl-2 phosphorylation-dependent manner. Dissociation of the Beclin 1:Bcl-2 complex, and the subsequent stimulation of autophagy have been observed in various contexts in which the cellular level of long-chain ceramides was increased. It is notable that the conversion of short-chain ceramides (C2-ceramide and C6-ceramide) into long-chain ceramide via the activity of ceramide synthase is required to trigger autophagy. The dissociation of the Beclin 1:Bcl-2 complex has also been observed in response to tamoxifen and PDMP (an inhibitor of the enzyme that converts ceramide to glucosylceramide), drugs that increase the intracellular level of long-chain ceramides. However, and in contrast to starvation, overexpression of Bcl-2 does not blunt ceramide-induced autophagy. Whether this autophagy that is unchecked by forced dissociation of the Beclin 1:Bcl-2 complex is related to the ability of ceramide to trigger cell death remains an open question. More generally, the question of whether ceramide-induced autophagy is a dedicated cell death mechanism deserves closer scrutiny.",
keywords = "Bcl-2, Beclin 1, c-Jun N-terminal kinase, Cell death, Macroautophagy, Sphingolipids",
author = "Sophie Pattingre and Chantal Bauvy and Thierry Levade and Beth Levine and Patrice Codogno",
year = "2009",
month = "5",
day = "16",
doi = "10.4161/auto.5.4.8390",
language = "English (US)",
volume = "5",
pages = "558--560",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Ceramide-induced autophagy

T2 - To junk or to protect cells?

AU - Pattingre, Sophie

AU - Bauvy, Chantal

AU - Levade, Thierry

AU - Levine, Beth

AU - Codogno, Patrice

PY - 2009/5/16

Y1 - 2009/5/16

N2 - Ceramide is a sphingolipid bioactive molecule that induces apoptosis and other forms of cell death, and triggers macroautophagy (referred to below as autophagy). Like amino acid starvation, ceramide triggers autophagy by interfering with the mTOR-signaling pathway, and by dissociating the Beclin 1:Bcl-2 complex in a c-Jun N-terminal kinase 1 (JNK1)-mediated Bcl-2 phosphorylation-dependent manner. Dissociation of the Beclin 1:Bcl-2 complex, and the subsequent stimulation of autophagy have been observed in various contexts in which the cellular level of long-chain ceramides was increased. It is notable that the conversion of short-chain ceramides (C2-ceramide and C6-ceramide) into long-chain ceramide via the activity of ceramide synthase is required to trigger autophagy. The dissociation of the Beclin 1:Bcl-2 complex has also been observed in response to tamoxifen and PDMP (an inhibitor of the enzyme that converts ceramide to glucosylceramide), drugs that increase the intracellular level of long-chain ceramides. However, and in contrast to starvation, overexpression of Bcl-2 does not blunt ceramide-induced autophagy. Whether this autophagy that is unchecked by forced dissociation of the Beclin 1:Bcl-2 complex is related to the ability of ceramide to trigger cell death remains an open question. More generally, the question of whether ceramide-induced autophagy is a dedicated cell death mechanism deserves closer scrutiny.

AB - Ceramide is a sphingolipid bioactive molecule that induces apoptosis and other forms of cell death, and triggers macroautophagy (referred to below as autophagy). Like amino acid starvation, ceramide triggers autophagy by interfering with the mTOR-signaling pathway, and by dissociating the Beclin 1:Bcl-2 complex in a c-Jun N-terminal kinase 1 (JNK1)-mediated Bcl-2 phosphorylation-dependent manner. Dissociation of the Beclin 1:Bcl-2 complex, and the subsequent stimulation of autophagy have been observed in various contexts in which the cellular level of long-chain ceramides was increased. It is notable that the conversion of short-chain ceramides (C2-ceramide and C6-ceramide) into long-chain ceramide via the activity of ceramide synthase is required to trigger autophagy. The dissociation of the Beclin 1:Bcl-2 complex has also been observed in response to tamoxifen and PDMP (an inhibitor of the enzyme that converts ceramide to glucosylceramide), drugs that increase the intracellular level of long-chain ceramides. However, and in contrast to starvation, overexpression of Bcl-2 does not blunt ceramide-induced autophagy. Whether this autophagy that is unchecked by forced dissociation of the Beclin 1:Bcl-2 complex is related to the ability of ceramide to trigger cell death remains an open question. More generally, the question of whether ceramide-induced autophagy is a dedicated cell death mechanism deserves closer scrutiny.

KW - Bcl-2

KW - Beclin 1

KW - c-Jun N-terminal kinase

KW - Cell death

KW - Macroautophagy

KW - Sphingolipids

UR - http://www.scopus.com/inward/record.url?scp=66349092892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349092892&partnerID=8YFLogxK

U2 - 10.4161/auto.5.4.8390

DO - 10.4161/auto.5.4.8390

M3 - Article

VL - 5

SP - 558

EP - 560

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 4

ER -